From 2007 to 2010, Suzhou Chireach research and produce hundreds of pharmaceutical intermediates, ten kinds of anti-Alzheimer and anti-neoplastic API. At present, we have cooperated with many famous pharmaceutical enterprises, eg. Pfizer, Novatis, Abbott, Lilly,TEVA,etc. We provide custom synthesis, chemical processing and manufacturing.
In the future, we will continue to keep leading technology and work on marketing, cooperated with the domestic and international well-known pharmaceutical factory, developing new products.
Our company totally has thirteen patents, six of them have been opened and seven have been accepted.
Production Process of Rivastigmine
Publication Number:CN101239934
Preparation method of (S)-4-Hydroxy-2-pyrrolidinone and its derivatives
Publication Number:CN101239938
Preparation method of Rasagiline
Publication Number: CN101260048
Preparation method of cidofovir and its intermediates
Publication Number: CN101525352
Preparation method of Naphthylamine and its derivative
Publication Number: CN101602680
Preparation method of Imidazolecarboxylate and its derivatives
Publication Number: CN101693694A
Preparation method of Rotigotine and its derivatives
Application Number :200910186194.8
Preparation method and application of acyclovir molecular imprinted polymer
Application Number :201010118951.0
Synthesis method of 3,4-ethylenedioxythiophene (EDOT)
Application Number :201010561954.1
Preparation method Of 3-Amino-2,2-dimethylpropionamide
Application Number: 201010561942.9
New Synthesis method of (S)-N-Azetidine-2-carboxylic acid
Application Number: 201010561958.X
New Synthesis method of ((S)-(+)-3-Hydroxytetrahydrofuran
Application Number: 201010561845.X
|